How stakeholder engagement influenced a randomized comparative effectiveness trial testing two Diabetes Prevention Program interventions in a Marshallese Pacific Islander Community

Pearl A. McElfish, Britni L. Ayers, Holly C. Felix, Christopher R. Long, Zoran Bursac, Joseph Keawe Aimoku Kaholokula, Sheldon Riklon, Williamina Bing, Anita Iban, Karen Hye Cheon Kim Yeary

Research output: Contribution to journalArticle

Abstract

Background: Marshallese face significant health disparities, with particularly high rates of type 2 diabetes. Engaging stakeholders in the research process is essential to reduce health inequities. Methods: A community- and patient-engaged research approach was used to involve community Marshallese stakeholders in a randomized comparative effectiveness trial testing two Diabetes Prevention Program interventions. Results: The article outlines the engagement process and the specific influence that stakeholders had on the research planning and implementation, discussing the areas of agreement and disagreement between community and patient stakeholders and academic investigators and documenting changes to the research protocol. Conclusion: The article provides an example of methods that can be used to design and conduct a randomized controlled trial testing with a population who has been underrepresented in research and suffered significant historical trauma.

Original languageEnglish (US)
Article number42
JournalJournal of Translational Medicine
Volume17
Issue number1
DOIs
StatePublished - Feb 11 2019

Fingerprint

Medical problems
Testing
Research
Health
Type 2 Diabetes Mellitus
Randomized Controlled Trials
Research Personnel
Planning
Wounds and Injuries
Population

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

How stakeholder engagement influenced a randomized comparative effectiveness trial testing two Diabetes Prevention Program interventions in a Marshallese Pacific Islander Community. / McElfish, Pearl A.; Ayers, Britni L.; Felix, Holly C.; Long, Christopher R.; Bursac, Zoran; Kaholokula, Joseph Keawe Aimoku; Riklon, Sheldon; Bing, Williamina; Iban, Anita; Yeary, Karen Hye Cheon Kim.

In: Journal of Translational Medicine, Vol. 17, No. 1, 42, 11.02.2019.

Research output: Contribution to journalArticle

McElfish, Pearl A. ; Ayers, Britni L. ; Felix, Holly C. ; Long, Christopher R. ; Bursac, Zoran ; Kaholokula, Joseph Keawe Aimoku ; Riklon, Sheldon ; Bing, Williamina ; Iban, Anita ; Yeary, Karen Hye Cheon Kim. / How stakeholder engagement influenced a randomized comparative effectiveness trial testing two Diabetes Prevention Program interventions in a Marshallese Pacific Islander Community. In: Journal of Translational Medicine. 2019 ; Vol. 17, No. 1.
@article{8dd5a0224138415a9d6490064beadff8,
title = "How stakeholder engagement influenced a randomized comparative effectiveness trial testing two Diabetes Prevention Program interventions in a Marshallese Pacific Islander Community",
abstract = "Background: Marshallese face significant health disparities, with particularly high rates of type 2 diabetes. Engaging stakeholders in the research process is essential to reduce health inequities. Methods: A community- and patient-engaged research approach was used to involve community Marshallese stakeholders in a randomized comparative effectiveness trial testing two Diabetes Prevention Program interventions. Results: The article outlines the engagement process and the specific influence that stakeholders had on the research planning and implementation, discussing the areas of agreement and disagreement between community and patient stakeholders and academic investigators and documenting changes to the research protocol. Conclusion: The article provides an example of methods that can be used to design and conduct a randomized controlled trial testing with a population who has been underrepresented in research and suffered significant historical trauma.",
author = "McElfish, {Pearl A.} and Ayers, {Britni L.} and Felix, {Holly C.} and Long, {Christopher R.} and Zoran Bursac and Kaholokula, {Joseph Keawe Aimoku} and Sheldon Riklon and Williamina Bing and Anita Iban and Yeary, {Karen Hye Cheon Kim}",
year = "2019",
month = "2",
day = "11",
doi = "10.1186/s12967-019-1793-7",
language = "English (US)",
volume = "17",
journal = "Journal of Translational Medicine",
issn = "1479-5876",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - How stakeholder engagement influenced a randomized comparative effectiveness trial testing two Diabetes Prevention Program interventions in a Marshallese Pacific Islander Community

AU - McElfish, Pearl A.

AU - Ayers, Britni L.

AU - Felix, Holly C.

AU - Long, Christopher R.

AU - Bursac, Zoran

AU - Kaholokula, Joseph Keawe Aimoku

AU - Riklon, Sheldon

AU - Bing, Williamina

AU - Iban, Anita

AU - Yeary, Karen Hye Cheon Kim

PY - 2019/2/11

Y1 - 2019/2/11

N2 - Background: Marshallese face significant health disparities, with particularly high rates of type 2 diabetes. Engaging stakeholders in the research process is essential to reduce health inequities. Methods: A community- and patient-engaged research approach was used to involve community Marshallese stakeholders in a randomized comparative effectiveness trial testing two Diabetes Prevention Program interventions. Results: The article outlines the engagement process and the specific influence that stakeholders had on the research planning and implementation, discussing the areas of agreement and disagreement between community and patient stakeholders and academic investigators and documenting changes to the research protocol. Conclusion: The article provides an example of methods that can be used to design and conduct a randomized controlled trial testing with a population who has been underrepresented in research and suffered significant historical trauma.

AB - Background: Marshallese face significant health disparities, with particularly high rates of type 2 diabetes. Engaging stakeholders in the research process is essential to reduce health inequities. Methods: A community- and patient-engaged research approach was used to involve community Marshallese stakeholders in a randomized comparative effectiveness trial testing two Diabetes Prevention Program interventions. Results: The article outlines the engagement process and the specific influence that stakeholders had on the research planning and implementation, discussing the areas of agreement and disagreement between community and patient stakeholders and academic investigators and documenting changes to the research protocol. Conclusion: The article provides an example of methods that can be used to design and conduct a randomized controlled trial testing with a population who has been underrepresented in research and suffered significant historical trauma.

UR - http://www.scopus.com/inward/record.url?scp=85061391710&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061391710&partnerID=8YFLogxK

U2 - 10.1186/s12967-019-1793-7

DO - 10.1186/s12967-019-1793-7

M3 - Article

C2 - 30744647

AN - SCOPUS:85061391710

VL - 17

JO - Journal of Translational Medicine

JF - Journal of Translational Medicine

SN - 1479-5876

IS - 1

M1 - 42

ER -